通过apremilast介导的抗Aβ诱导的细胞毒性保护与PI3K/Akt通路激活相关
1Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Neuroscience
|December 24, 2025
概括
作为PDE4抑制剂的阿普雷米拉斯特通过激活PI3K/Akt通路,在细胞模型中显示出保护细胞免受β-粉样蛋白诱导的神经毒性的前景. 需要进一步的体内研究来确认它对阿尔茨海默氏症的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 阿普雷米拉斯特是一种固酶-4 (PDE4) 抑制剂,具有抗炎和神经保护性质.
- 它的特征表明它有可能成为阿尔茨海默病 (AD) 的治疗候选者.
研究的目的:
- 为了研究阿普雷米拉斯特在微质和海马细胞系中对粉样β (Aβ) 诱导的毒性产生神经保护作用.
- 探索潜在的分子机制,重点关注PI3K/Akt信号通路.
主要方法:
- 网络药理学和分子对接确定了潜在的目标.
- 细胞计数工具-8 (CCK-8) 测试评估了细胞活力.
- 西方斑点分析检查了PI3K/Akt路径蛋白质表达.
主要成果:
- 阿普雷米拉斯特显著抵消了Aβ诱导的细胞毒性,改善了BV2和HT-22细胞中的细胞活力.
- 西部斑点分析显示,酸化Akt (p-Akt/Akt) 和PI3K蛋白水平的上调.
结论:
- 阿普雷米拉斯特通过调节PI3K/Akt路径,证明了对Aβ诱导的细胞毒性产生神经保护作用.
- 需要进一步对Apremilast的剂量和疗效进行体内验证.
更多相关视频
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
9.0K
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.5K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
The Extrinsic Apoptotic Pathway
8.0K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.0K
